Top

Systematic Reviews

Published in:

Open Access 01-12-2018 | Protocol

Evidence of patients’ challenges and barriers related to usage of Implanon®: scoping review protocol

Authors: Shimona Prosad, Tivani P Mashamba-Thompson, Elizabeth Ojewole

Published in: Systematic Reviews | Issue 1/2018

Abstract

Background

According to the United Nations Trends in Contraceptive Use 2015 report, at least one in ten married or in-union women in most regions of the world has an unmet need for family planning. Family Planning 2020 reports an estimate of almost 134 million married or in-union women of reproductive age who have an unmet need for modern methods of contraception in 2016 in participating countries. Family planning has therefore been highlighted as a global unmet need. Initiatives such as Family Planning 2020 aim to promote contraceptive use through Implanon® contraceptive implant. Implanon® has been reported to be a highly effective form of contraception. However, poor outcomes from users of the Implanon® have been reported in recent studies. The main objective of this review is to map the literature for the evidence on usage of Implanon® in order to reveal challenges and barriers.

Methods and analysis

A scoping review searching evidence on Implanon® use will be conducted. Relevant studies will be identified from 1998 to present. The following databases: PubMed, MEDLINE, EBSCOhost, Google Scholar and Cochrane library will be searched for peer-reviewed literature. We will also search for grey literature in this study area. The eligibility criteria will guide the study selection. A data charting table will be designed to extract information from the literature. The results of this study will be reported by use of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Data will be analysed using thematic analysis and the NVIVO software version 10. The mixed method appraisal tool (MMAT) will be used to assess the quality of included studies.

Discussion

We anticipate finding relevant studies on the use of Implanon®. Evidence gathered from included studies will help us identify gaps in research and help guide future research on Implanon® usage. This information can also help guide implementers and users on challenges and barriers related to use of Implanon®.

Systematic review registration

PROSPERO CRD42017072926.

Available only for authorised users

Darney P, Patel A, Rosen K, Shapiro LS, Kaunitz AM. Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials. Fertil Steril. 2009;91:1646–53.CrossRef

Department of Economic and social affairs population division. Trends in Contraceptive Use Worldwide 2015. 2015. http://www.un.org/en/development/desa/population/publications/pdf/family/trendsContraceptiveUse2015Report.pdf. Accessed 13 Apr 2017.

Scoggins S, Bremner J. FP2020 Momentum at the Midpoint 2015–2016 Progress report. 2016. http://2015-2016progress.familyplanning2020.org/uploads/05/15/FP2020_DIGITAL_Spreads_LoRes.pdf. Accessed 13 Apr 2017.

Hohmann H. Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive. Patient Prefer Adherence. 2009;3:205–11.CrossRef

Roberts, A O, Morhason-Bello, I O, ., Okunlola, M A Profile of Implanon acceptors and pattern of side effects J Reprod Contracept 2015;26:46–52. doi:https://doi.org/10.7669/j.issn.1001-7844.2015.01.0046.CrossRef

Ojule J, Oranu E, Enyindah C. Experience with Implanon in Southern Nigeria. J Med Med Sci. 2012;3:710–4.

Merck Sharp & Dohme. Implanon NXT ® Product Information. 2015.

Creinin MD, Kaunitz AM, Darney PD, Schwartz L, Hampton T, Gordon K, et al. The US etonogestrel implant mandatory clinical training and active monitoring programs: 6-year experience. Contraception. 2017;95:205–10. https://doi.org/10.1016/j.contraception.2016.07.012.CrossRefPubMed

Bitzer J, Tschudin S, Alder J. The Swiss Implanon Study Group the SIS. Acceptability and side-effects of Implanon in Switzerland: a retrospective study by the Implanon Swiss Study Group. Eur J Contracept Reprod Heal Care. 2004;9:278–84. https://doi.org/10.1080/13625180400017503.CrossRef

10.

Harrison-Woolrych M, Hill R. Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia. Contraception. 2005;71:306–8. https://doi.org/10.1016/j.contraception.2004.10.005.CrossRefPubMed

11.

Lince-Deroche N, Pleaner M, Harries J, Morroni C, Mullick S, Firnhaber C, et al. Achieving universal access to sexual and reproductive health services: the potential and pitfalls for contraceptive services in South Africa. 2016.

12.

Patel RC, Onono M, Gandhi M, Blat C, Hagey J, Shade SB, et al. Pregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort study. Lancet HIV. 2015;2:e474–82.CrossRef

13.

United Nations General Assembly. Transforming our world: the 2030 agenda for sustainable development. 2015.

14.

Republic of South Africa National Department of Health. National Contraception Clinical Guidelines 2012. Pretoria: Department of Health; 2013.

15.

Merck Sharp & Dohme B.V. IMPLANON® (etonogestrel implant) FDA approved labelling. 2016.

16.

Colquhoun HL, Levac D, O’Brien KK, Straus S, Tricco AC, Perrier L, et al. Scoping reviews: time for clarity in definition, methods, and reporting. J Clin Epidemiol. 2014;67:1291–4. https://doi.org/10.1016/j.jclinepi.2014.03.013.CrossRefPubMed

17.

Arksey H, O ‘malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8:19–32. https://doi.org/10.1080/1364557032000119616.CrossRef

18.

Davies KS. Formulating the evidence based practice question: a review of the frameworks. Evid Based Libr Inf Pract. 2011;6:75–80.CrossRef

19.

Castleberry A. NVivo 10 [software program]. Version 10. QSR International; 2012. Am J Pharm Educ. 2014;78:25. https://doi.org/10.5688/ajpe78125.CrossRefPubMedCentral

20.

Pluye P, Robert E, Cargo M, Bartlett G. Proposal: a mixed methods appraisal tool for systematic mixed studies reviews. Montréal McGill Univ. 2011;Part I:1–8 http://mixedmethodsappraisaltoolpublic.pbworks.com/w/file/84371689/MMAT 2011 criteria and tutorial 2011–06-29updated2014.08.21.pdf.

21.

Ezegwui HU, Ikeako LC, Ishiekwene CIC, Oguanua TC. The discontinuation rate and reasons for discontinuation of Implanon at the family planning clinic of University of Nigeria Teaching Hospital (UNTH) Enugu, Nigeria. Niger J Med. 2010;20:448–50 http://www.ncbi.nlm.nih.gov/pubmed/22288321.

22.

Mukherjee S, Sen S, Kelaiselvan V, Tripathi S. Consumer reporting of adverse drug reactions. Int J Green Pharm. 2016;10:136–42. https://doi.org/10.15252/embr.201642616.CrossRef

Title: Evidence of patients’ challenges and barriers related to usage of Implanon®: scoping review protocol
Authors: Shimona Prosad
Tivani P Mashamba-Thompson
Elizabeth Ojewole
Publication date: 01-12-2018
Publisher: BioMed Central
Published in: Systematic Reviews / Issue 1/2018
Electronic ISSN: 2046-4053
DOI: https://doi.org/10.1186/s13643-018-0827-1

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Evidence of patients’ challenges and barriers related to usage of Implanon®: scoping review protocol

Abstract

Background

Methods and analysis

Discussion

Systematic review registration

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Methods and analysis

Discussion

Systematic review registration

Please log in to get access to this content

Other articles of this Issue 1/2018

Parent-to-parent support interventions for parents of babies cared for in a neonatal unit—protocol of a systematic review of qualitative and quantitative evidence

Evaluation of the reliability, usability, and applicability of AMSTAR, AMSTAR 2, and ROBIS: protocol for a descriptive analytic study

Reflections and aspirations: the journal after 5 years

Bioactive scaffolds in stem-cell-based therapies for cardiac repair: protocol for a meta-analysis of randomized controlled preclinical trials in animal myocardial infarction models

HIV-related data among key populations to inform evidence-based responses: protocol of a systematic review

Understanding variations in catastrophic health expenditure, its underlying determinants and impoverishment in Sub-Saharan African countries: a scoping review